|
Market Cap (18-May) $1,025,901,888 (311th) |
Close (30-Jun) $1.55 |
Volume (30-Jun) 1,225,647 |
Shortsold (5-May) 71,471,994 (10.35%) (8th) |
|
52w High $2.78 |
52w Low $0.93 |
P/E 70.92 |
EPS 0.01 |
PNV released this announcement to the ASX on 26 February 2021, 9:44. The announcement is not marked as price sensitive, and is 2 page(s) in length and 182.88kb in size.
You can view all announcements from PNV and see how they appear on a price chart on the announcements page.
At the date of this announcement, PNV was 4.442% short sold according to ASIC data. It was ranked the 31st most shorted stock on the ASX. It is now ranked as the 8th most shorted stock on the ASX with 10.346% of total shares short sold as of the latest reported data (05 May 2025).
| Other Recent Announcements from PNV | |
|---|---|
| Appendix 3Y - Robyn Elliott | 30 June 2023, 10:41 |
| Director Share Purchase - David Williams | 8 June 2023, 15:14 |
| Director Share Purchase - David Williams | 8 June 2023, 8:19 |
| Chronic wound reimbursement study - first patient recruited | 26 February 2021, 9:44 |
| Distributor App. - PolyNovo enters Denmark, Norway & Iceland | 25 February 2021, 9:41 |
| H1 FY21 Results Investor Presentation | 23 February 2021, 9:15 |
| Appendix 4D and H1 FY21 Report | 23 February 2021, 9:14 |
You must be logged in to post a reply.
PolyNovo 